Where does Antares Pharma, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Antares Pharma, Inc. ranks #4,318 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Antares Pharma, Inc. hold?

Antares Pharma, Inc. holds 82 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is Antares Pharma, Inc.'s Innovation Score?

Antares Pharma, Inc. has an Innovation Score of 40.0 out of 100 (top 37% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Antares Pharma, Inc.'s patent grant rate increasing or decreasing?

Antares Pharma, Inc.'s recent grant velocity is +29% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Antares Pharma, Inc.'s patents?

Antares Pharma, Inc.'s patents average 19.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Antares Pharma, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Antares Pharma, Inc.

Q: What technology areas does Antares Pharma, Inc. focus on?

Antares Pharma, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 74 patents. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 82 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Antares ranks #4,318 of 49,997 tracked US assignees by granted-patent volume, with 82 patents across 6 technology areas.

#4,318
of 49,997 US assignees by volume: Top 37%
by Innovation Score (40.0/100): 19.5
avg claims per patent: +29%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4318 · US Corporation #4,318 · 82 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 82 grants
TOP-DECILE #4,318/49,997
PHOTO-FINISH Acucela
CPC-NARROW A61M · 6 areas
INNOV-THIN 40.0/100
CLAIMS-RICH 19.5 claims/avg
TYPE-USCORP US Corporation
VEL-UP +29% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Acucela Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Antares Pharma · this assignee

40
Hosokawa Yoko · near

40
Janssen Sciences… · near

40
Jiangsu Midea… · near

40
Luxottica S R L · near

40
3D Lighting… · lowest

7

What this shows Antares's Innovation Score is 40.0/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Antares's grants concentrate

Antares Pharma, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 90.2% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2020 (12 grants) versus a trough of 4 in 2015. By volume, Antares sits between Acucela Inc. and CBS Interactive Inc..

Antares's three-year grant acceleration

From 2019–2021 to 2022–2024, Antares Pharma, Inc. moved from 32 to 21 grants (0.66x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Acucela

82
Appleton GRP

82
Airoha Technology

82
Andersen

82
Balluff

82
Byk-chemie

82
Bedgear

82
CBS Interactive

82
Antares Pharma ◀

82

What this shows Antares holds 82 patents at rank #4,319, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Antares

By rank, the assignees closest to #4,319 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Antares's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Antares, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Janssen Sciences Ireland Unlimited Company 40 Luxottica S.R.L. 40 Jiangsu Midea Cleaning Appliances Co., Ltd. 40 Hosokawa Yoko Co., Ltd. 40

Similar claim depth

Nearest assignees by average claims per patent (19.5 here).

Hill Phoenix, Inc. 19.5 avg Tectus Corporation 19.5 avg Preformed Line Products Co. 19.5 avg D.R. Systems, Inc. 19.5 avg

Antares's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Antares Pharma, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	4.9%
2016	7	8.5%
2017	10	12.2%
2018	4	4.9%
2019	9	11.0%
2020	12	14.6%
2021	11	13.4%
2022	5	6.1%
2023	9	11.0%
2024	7	8.5%
2025partial year	4	4.9%

Which technologies does Antares Pharma, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 74

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 25

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 22

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 3

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 2

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 2

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#4,318

of 49,997 tracked assignees

Innovation Score

40.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Antares Pharma, Inc.'s patent record in context - here's where to go next.

Antares Pharma, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 90.2% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #4,318 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Antares Pharma, Inc. against Acucela Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.